shortagewatch

Home / Cancer and immune system / Lapatinib

ATC L01XE07 · Protein Kinase Inhibitors · updated 2 Nov 2026

Lapatinib shortage

As of 2 Nov 2026, Lapatinib has a reported shortage in 1 of the 16 countries we track (Japan), covering 1 product from 1 company.

Is there a Lapatinib shortage?

Yes. As of 2 Nov 2026, Lapatinib is reported short in 1 of the 16 countries we track: Japan. No company has given a return date.

Countries1/16
Products1packs or presentations
Companies11 listed
Short since15 Sep 202648 days ago
Earliest returnnot givencompany estimate
Main reasonQuality problem or recall

Timeline

Japan
タイケルブ錠250mgタイケルブ錠250mgtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Novartis1 NOVN

Listed: Novartis NOVN · SIX Swiss

Compared with similar medicines

ATC group L01XE · Protein Kinase Inhibitors
Gefitinib1/16Imatinib1/16Lapatinib1/16

Affected products

CountryProductCompanySinceExpected backReason
タイケルブ錠250mg limitedNovartis15 Sep 2026not givenQuality problem or recall
Quality problem

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Lapatinib shortage?

Yes. As of 2 Nov 2026, Lapatinib is reported short in 1 of the 16 countries we track: Japan. No company has given a return date.

When will Lapatinib be back in stock?

No return date has been given; Japan: no date given. These are company estimates reported to each authority.

Why is Lapatinib in short supply?

The most common reason reported is: quality problem or recall. Reasons by product are listed in the table below.

Which companies have Lapatinib shortages?

Novartis.